
The Global Fund talks a lot about transparency -- and acts on its word. Their
Web site is an impressive testament to transparency, providing detailed information on proposals, grants and funding for the world to see.
Efforts at transparency should continue to improve. One feature The Global Fund will be launching shortly is a "drug price database" which will track the procurement price of ARV medicines as reported by all grant recipients. This will provide a powerful mechanism for promoting lower and lower procurement costs. Web-based "disclosure" programs of this sort have been powerfully adopted in other sectors (environmental issues, campaign subsidies), but this is the first good example I've seen applied to AIDS. In a perfect world there would be a parallel
"black market" database, but congratulations to the Global Fund for moving this issue in a very smart direction.
In coming years there will be billions of dollars spent on AIDS medicines, most on generic drugs. The future of the AIDS response pivots on these purchases: they are the biggest line item in most AIDS programs, and programs and individuals will become
Tracked: Jul 23, 13:43